how to prevent muscle loss with glp 1 Weight GLP-1 medicines does not result in a disproportionate loss of mass or function in obese mice and humans GLP-1 preauthorization: Why movement-first strategies
Description
Over 5,000 scientific studies have been performed with berberine, including over 150 human clinical trials
These immunomodulatory effects point toward a promising adjunctive strategy in current clinical practice for patients with rheumatic diseases, particularly those with metabolic comorbidities
Semaglutides direct CV benefits stem from its anti-inflammatory properties, as it reduces systematic inflammation, lowers CV damage, and slows the progression of CVD [36]
In contrast, there was limited benefit in patients with established cirrhosis
PMID: 37276988
